GET THE APP

Drug Designing: Open Access
Open Access

ISSN: 2169-0138

+44 1223 790975

Drug Designing: Open Access : Citations & Metrics Report

Articles published in Drug Designing: Open Access have been cited by esteemed scholars and scientists all around the world. Drug Designing: Open Access has got h-index 9, which means every article in Drug Designing: Open Access has got 9 average citations.

Following are the list of articles that have cited the articles published in Drug Designing: Open Access.

	2021	2020	2019	2018	2017	2016
Year wise published articles	31	67	2	5	16	18
Year wise citations received	50	43	38	38	22	46

Journal total citations count	368
Journal impact factor	1.70
Journal 5 years impact factor	1.5
Journal cite score	1.57
Journal h-index	9
Journal h-index since 2018	7

Important citations (297)

Optimisation of ethosomal nanogel for topical nano-cur and sulphoraphane delivery in effective skin cancer therapy View at Publisher View at Google Scholar View at Indexing
A bioassay system for pharmacological standardization of withania somnifera derived herbal remedies View at Publisher View at Google Scholar View at Indexing
Triethylene glycol-like effects of ashwagandha (withania somnifera (l.) dunal) root extract devoid of withanolides in stressed mice View at Publisher View at Google Scholar View at Indexing
Conducting clinical trials in emerging markets of sub-saharan africa: review of guidelines and resources for foreign sponsors View at Publisher View at Google Scholar View at Indexing
Design, synthesis, antitubercular and antimicrobial activities of novel thiazole substituted benzimidazole derivatives View at Publisher View at Google Scholar View at Indexing
Fast dissolving drug delivery system: a review View at Publisher View at Google Scholar View at Indexing
Principles involved in bioassay by different methods: a mini-review View at Publisher View at Google Scholar View at Indexing
Licofelone, a potent cox/5-lox inhibitor and a novel option for treatment of neurological disorders View at Publisher View at Google Scholar View at Indexing
Stat3 transcription factor as target for anti-cancer therapy View at Publisher View at Google Scholar View at Indexing
De-novo ligand design against mutated huntington gene by ligand-based pharmacophore modeling approach View at Publisher View at Google Scholar View at Indexing
Vibrational analysis and molecular docking studies on some ribonuclease-h hiv inhibitors View at Publisher View at Google Scholar View at Indexing
Evaluation of pterin, a promising drug candidate from cyanide degrading bacteria. View at Publisher View at Google Scholar View at Indexing
Combinatorial analysis of gene regulatory network reveals the causal genetic basis of breast cancer and gene-specific personalized drug treatments View at Publisher View at Google Scholar View at Indexing
Cancer treatment by caryophyllaceae-type cyclopeptides. View at Publisher View at Google Scholar View at Indexing
Peptides with dual antimicrobial-anticancer activity derived from the n-terminal region of h. pylori ribosomal protein l1 (rpl1) View at Publisher View at Google Scholar View at Indexing
Fast dissolving drug delivery system: a review View at Publisher View at Google Scholar View at Indexing
On the critical review of five machine learning-based algorithms for predicting protein stability changes upon mutation View at Publisher View at Google Scholar View at Indexing
A critical review of five machine learning-based algorithms for predicting protein stability changes upon mutation. View at Publisher View at Google Scholar View at Indexing
Review on: adverse drug reactions of chemotherapy drugs View at Publisher View at Google Scholar View at Indexing
A review on targeted drug delivery system - nanoparticles View at Publisher View at Google Scholar View at Indexing
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next »

Top